Quarterly report pursuant to Section 13 or 15(d)

Net (Loss) Income Per Share (Schedule Of Earnings Per Share, Basic And Diluted) (Details)

v3.21.2
Net (Loss) Income Per Share (Schedule Of Earnings Per Share, Basic And Diluted) (Details) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Jun. 30, 2021
Jun. 30, 2020
Schedule of Earnings Per Share, Basic and Diluted [Line Items]                
Net (loss) income $ (2,692,866) $ (2,845,981) $ 17,227,701 $ (3,025,380) $ (810,509) $ (3,305,101) $ 11,688,854 $ (7,140,990)
Basic weighted average common shares outstanding 79,729,370     66,728,782     75,054,871 65,709,139
Common stock purchase warrants             499,783  
Total net effect of dilutive instruments             7,752,285  
Diluted weighted average common shares outstanding 79,729,370     66,728,782     82,807,156 65,709,139
Net (loss) income per basic common share outstanding $ (0.03)     $ (0.05)     $ 0.16 $ (0.11)
Net (loss) income per diluted common share outstanding $ (0.03)     $ (0.05)     $ 0.14 $ (0.11)
Stock Options [Member]                
Schedule of Earnings Per Share, Basic and Diluted [Line Items]                
Net effect of dilutive instruments             7,208,123  
Stock Appreciation Rights (SARs) [Member]                
Schedule of Earnings Per Share, Basic and Diluted [Line Items]                
Net effect of dilutive instruments             44,379